1. JAG1 intracellular domain acts as a transcriptional cofactor that forms an oncogenic transcriptional complex with DDX17/SMAD3/TGIF2
- Author
-
Jin Young Kim, Se Yeon Choi, Kyung Hoon Min, S. H. Kim, Xiong Jin, Jeong S, Hyunyong Kim, Jong Hyun Jang, Sunyoung Seo, Eunhye Kim, Seok Won Ham, Nayoung Hong, Kisung Lee, Jeong Hj, Mingu Gordon Park, Sokho Kim, and Sung Eun Kim
- Subjects
JAG1 ,biology ,Chemistry ,Cancer ,medicine.disease ,Cofactor ,Cell biology ,Transcriptome ,Transformation (genetics) ,SOX2 ,Cancer stem cell ,medicine ,biology.protein ,Receptor - Abstract
Jagged1 (JAG1) is a Notch ligand that contact-dependently activates Notch receptors and regulates cancer progression. The JAG1 intracellular domain (JICD1) is generated from JAG1, such as the formation of NOTCH1 intracellular domain (NICD1), however, the role of JICD1 in tumorigenicity has not been comprehensively elucidated. Herein, we revealed that JICD1 induced astrocytes to acquire several cancer stem cell properties, including tumor formation, invasiveness, stemness, and resistance to chemotherapy and radiotherapy. The transcriptome, ChIP-sequencing, and proteomic analyses revealed that JICD1 increased SOX2 expression by forming a transcriptional complex with DDX17, SMAD3, and TGIF2. Furthermore, JICD1-driven tumorigenicity was directly regulated by SOX2. Therefore, our results demonstrated that, like NICD1, JICD1 acts as a transcriptional cofactor in the formation of the DDX17/SMAD3/TGIF2 transcriptional complex, leading to oncogenic transformation.
- Published
- 2021
- Full Text
- View/download PDF